Simultaneous quantitative analysis of olmesartan medoxomil and amlodipine besylate in plasma by high-performance liquid chromatography technique

Journal of Young Pharmacists

Volumn 4, Issue 2, 2012, Pages 88-94

  Shah, S K ^a   Asnani, A J ^b   Kawade, D P ^b   Dangre, S C ^c   Arora, S K ^d   Yende, S R ^e  

^a New Kamptee   (India)

^b Maharashtra Industrial Development Corporation India   (India)

^c Nagar Yuwak Shikshan Sanstha   (India)

^d Department of Pharmaceutical Science ^*  (India)

^e Near CP Foundry   (India)

Author keywords

Amlodipine besylate; high performance liquid chromatography; olmesartan medoxomil; plasma

Indexed keywords

ACETONITRILE; AMLODIPINE BESYLATE; AMMONIUM ACETATE; OLMESARTAN; TRIETHYLAMINE;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG DETERMINATION; DRUG HALF LIFE; DRUG MONITORING; DRUG STRUCTURE; FLOW RATE; LIMIT OF DETECTION; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PH MEASUREMENT; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; RAT; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84862601364     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.4103/0975-1483.96622     Document Type: Article

References (24)

1. Arrowsmith JE, Campbell SF, Cross PE, Stubbs JK, Burges RA, Gardiner DG, et al. Long-acting dihydropyridine calcium antagonists. J Med Chem 1986;29:1696-702.
2. Abernethy D. The pharmacokinetic profile of amlodipine. Am Heart J 1989;118:1100-3. (Pubitemid 19266092)
3. Meredith P, Elliott H. Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet 1992;22:22-31.
4. Krol G, Noe A, Yeh S, Raemsch K. Gas and liquid chromatographic analyses of nimodipine calcium antagonist in blood plasma and cerebrospinal fluid. J Chromatogr 1984;305:105-18. (Pubitemid 14185652)
5. Bereford A, MaCrae P, Stopher D, Wood B. Analysis of amlodipine in human plasma by gas chromatography. J Chromatogr 1987;420:178-83. (Pubitemid 17143239)
6. Higuchi S, Kawamura S. Specific determination of plasma nicardipine hydrochloride levels by gas chromatography-mass spectrometry. J Chromatogr 1981;223:341-9. (Pubitemid 11085272)
7. Maurer HH, Arlt JW. Screening procedure for detection of dihydropyridine calcium channel blocker metabolites in urine as part of a systematic toxicological analysis procedure for acidic compounds by gas chromatography-mass spectrometry after extractive methylation. J Anal Toxicol 1999;23:73-80. (Pubitemid 29143069)
8. Shimooka K, Sawada Y, Tatematsu H. Analysis of amlodipine in serum by a sensitive high-performance liquid chromatographic method with amperometric detection. J Pharm Biomed Anal 1989;7:1267-72. (Pubitemid 20089187)
9. Pollen K, Yeung F, Mosher S, Pollak P. Liquid chromatography assay for amlodipine: Chemical stability and pharmacokinetics in rabbits. J Pharm Biomed Anal 1991;9:565-71.
10. Josefsson M, Norlander B. Coupled-column chromatography on a Chiral-AGP phase for determination of amlodipine enantiomers in human plasma: An HPLC assay with electrochemical detection. J Pharm Biomed Anal 1996;15:267-77. (Pubitemid 26353862)
11. Tatar S, Atmaca S. Determination of amlodipine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr B 2001;758:305-10. (Pubitemid 32524027)
12. Bahrami G, Mirzaeei S. Simple and rapid HPLC method for determination of amlodipine in human serum with fluorescence detection and its use in pharmacokinetic studies. J Pharm Biomed Anal 2004;36:163-8. (Pubitemid 39209420)
13. Zhong D, Chen X, Gu J, Li X, Guo J. Applications of liquid chromatography- tandem mass spectrometry in drug and biomedical analyses. Clin Chim Acta 2001;313:147-50. (Pubitemid 33016705)
14. Chen L, Zhou L, Shen M, Ma A. Simultaneous determination and pharmacokinetic study of metformin and rosiglitazone in human plasma by HPLC-ESI-MS. J Chromatogr Sci 2011;49:94-100.
15. Streel B, Laine C, Zimmer C, Sibenaler R, Ceccato A. Enantiomeric determination of amlodipine in human plasma by liquid chromatography coupled to tandem mass spectrometry. J Biochem Biophys Methods 2002;54:357-68. (Pubitemid 36126154)
16. Rojanasthien N, Teekachunhatean S, Jakob K, Gaupp M, Arnold P, Chaichana N, et al. Bioequivalence study of generic amlodipine in healthy Thai male volunteers. Int J Clin Pharmacol Ther 2004;42:330-5. (Pubitemid 38787278)
17. Koga K, Yamagishi S, Takeuchi M, Inagaki Y, Amano S, Okamoto T, et al. CS-866, a new angiotensin II type 1 receptor antagonist, ameliorates glomerular anionic site loss and prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats. Mol Med 2002;8:591-9. (Pubitemid 36337504)
18. Schwocho L, Masonson H. Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects. J Clin Pharmacol 2001;41:515-27. (Pubitemid 32381869)
19. Nakamura H, Inoue T, Arakawa N, Shimizu Y, Yoshigae Y, Fujimori I, et al. Pharmacological and pharmacokinetic study of olmesartan medoxomil in animal diabetic retinopathy models. Eur J Pharmacol 2005;512:239-46. (Pubitemid 40544359)
20. Sellin L, Stegbauer J, Laeis P, Rump LC. Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension. J Hypertens 2005;23:2083-92. (Pubitemid 41830405)
21. Abernethy DR. The pharmacokinetic profile of amlodipine. Am Heart J 1989;118:1100-3. (Pubitemid 19266092)
22. Carvalho M, Oliveira CH, Mendes GD, Sucupira M, Moraes ME, De Nucci G. Amlodipine bioequivalence study: Quantification by liquid chromatography coupled to tandem mass spectrometry. Biopharm Drug Dispos 2001;22:383-90. (Pubitemid 34187853)
23. US Department of Health and Human Services Food and Drug Administration, Guidance for Industry: Bioanalytical Method validation. US Department of Health and Human Services: Rockville, MD; 2001.
24. Zarghi A, Foroutan SM, Shafaati A, Khoddam A. Validated HPLC method for determination of amlodipine in human plasma and its application to pharmacokinetic studies. Farmaco 2005;60:789-92. (Pubitemid 41317706)